Haemonetics Corp
NYSE:HAE
Haemonetics Corp
Net Income (Common)
Haemonetics Corp
Net Income (Common) Peer Comparison
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Haemonetics Corp
NYSE:HAE
|
Net Income (Common)
$126.5m
|
CAGR 3-Years
5%
|
CAGR 5-Years
22%
|
CAGR 10-Years
13%
|
|
Cooper Companies Inc
NYSE:COO
|
Net Income (Common)
$290.8m
|
CAGR 3-Years
-49%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
0%
|
|
DENTSPLY SIRONA Inc
NASDAQ:XRAY
|
Net Income (Common)
-$95m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
38%
|
CAGR 10-Years
N/A
|
|
Align Technology Inc
NASDAQ:ALGN
|
Net Income (Common)
$462.2m
|
CAGR 3-Years
0%
|
CAGR 5-Years
4%
|
CAGR 10-Years
13%
|
|
Lantheus Holdings Inc
NASDAQ:LNTH
|
Net Income (Common)
$460.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
61%
|
CAGR 10-Years
N/A
|
See Also
What is Haemonetics Corp's Net Income (Common)?
Net Income (Common)
126.5m
USD
Based on the financial report for Dec 30, 2023, Haemonetics Corp's Net Income (Common) amounts to 126.5m USD.
What is Haemonetics Corp's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
13%
Over the last year, the Net Income (Common) growth was 32%. The average annual Net Income (Common) growth rates for Haemonetics Corp have been 5% over the past three years , 22% over the past five years , and 13% over the past ten years .